Three departments: launching pilot work on expanding opening up in the medical field

On September 8th, the Ministry of Commerce, the National Health Commission, and the State Food and Drug Administration issued a notice on expanding the opening-up pilot work in the medical field. From the date of issuance of this notice, in the China (Beijing) Pilot Free Trade Zone, China (Shanghai) Pilot Free Trade Zone, China (Guangdong) Pilot Free Trade Zone and Hainan Free Trade Port, foreign-invested enterprises are allowed to engage in the development and application of human stem cell, gene diagnosis and therapy technologies for product registration, listing and production. All products that have been registered for listing and approved for production can be used nationwide.